Correction: SIK2 maintains breast cancer stemness by phosphorylating LRP6 and activating Wnt/ß-catenin signaling.
Oncogene
; 41(27): 3585, 2022 Jul.
Article
in En
| MEDLINE
| ID: mdl-35701535
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Oncogene
Year:
2022
Document type:
Article